Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sykes vet (international) pty. ltd. - potassium acetate; potassium citrate - oral solution/suspension - potassium acetate mineral-potassium active 41.7 g/l; potassium citrate mineral-potassium active 41.7 g/l - genitourinary system - dog | bitch | castrate | puppy - diuretic, acidifier or alkaliniser | acidification | acidifier | acidifying | acidosis | alkaliniser | bronchodilator | cardiac stimulant | dehydration | diuresis | diuretic | feline struvite urolithias | fluid retention | hepatotoxic drugs | kidney antiseptic | liver damage | methionine treatment | oedema | parturient udder oedema | retention of fluid | saluresis | stimulant - cardiac | struvite urolithiasis | tonus-improving | tying-up | udder oedema | urinary alkalizer | urinary antiseptic | urinary buffer | urinary calculi | urine | urolithiasis | uterine pessaries

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 6.5mmol) effervescent tablets bpc 1968 (actavis uk ltd - potassium bicarbonate; potassium acid tartrate - effervescent tablet - 500mg ; 300mg

Israel - engelsk - Ministry of Health

lapidot medical import and marketing ltd - potassium chloride - concentrate for solution for infusion - potassium chloride 14.9 g / 100 ml - potassium chloride - potassium chloride - treatment of potassium deficiency states when oral replacement is not feasable.

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 13.3mmol/5ml) solution for infusion 5ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 200mg/1ml

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 20mmol/10ml) solution for infusion 10ml ampoules (hameln pharma ltd - potassium chloride - solution for infusion - 150mg/1ml

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 13.3mmol/5ml) solution for infusion 5ml ampoules (hameln pharma ltd - potassium chloride - solution for infusion - 200mg/1ml

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 27mmol/10ml) solution for infusion 10ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 200mg/1ml

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium 20mmol/10ml) solution for infusion 10ml ampoules (advanz pharma - potassium chloride - solution for infusion - 150mg/1ml

Israel - engelsk - Ministry of Health

medic trim healthcare ltd - potassium chloride - solution for injection - potassium chloride 1.5 g / 10 ml - potassium chloride - potassium chloride - potassium deficiency.

USA - engelsk - NLM (National Library of Medicine)

strides pharma inc. - potassium citrate (unii: ee90oni6ff) (anhydrous citric acid - unii:xf417d3psl) - potassium citrate 5 meq - potassium citrate is indicated for the management of renal tubular acidosis [see clinical studies (14.1)] . potassium citrate is indicated for the management of hypocitraturic calcium oxalate nephrolithiasis [see clinical studies (14.2)] . potassium citrate is indicated for the management of uric acid lithiasis with or without calcium stones [see clinical studies (14.3)] . potassium citrate extended-release tablets are contraindicated: • in patients with hyperkalemia (or who have conditions predisposing them to hyperkalemia), as a further rise in serum potassium concentration may produce cardiac arrest. such conditions include: chronic renal failure, uncontrolled diabetes mellitus, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown or the administration of a potassium-sparing agent (such as triamterene, spironolactone or amiloride). • in patients in whom there is cause for arrest or delay in tablet passage through the gastrointestinal